BI Asset Management Fondsmaeglerselskab’s Bristol-Myers Squibb BMY Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.5M	Buy	1,033,357 +465,977	+82%	+$26.8M	0.47%	40
2026 Q1	$34.4M	Buy	567,380 +372,897	+192%	+$21.7M	0.36%	54
2025 Q4	$10.5M	Sell	194,483 -34,810	-15%	-$1.67M	0.09%	167
2025 Q3	$10.3M	Buy	229,293 +13,703	+6%	+$640K	0.09%	167
2025 Q2	$9.98M	Buy	215,590 +134,492	+166%	+$6.6M	0.1%	173
2025 Q1	$4.95M	Sell	81,098 -186,555	-70%	-$10.9M	0.06%	235
2024 Q4	$15.1M	Buy	267,653 +163,121	+156%	+$9.11M	0.16%	124
2024 Q3	$5.41M	Buy	104,532 +59,326	+131%	+$2.78M	0.09%	170
2024 Q2	$1.88M	Buy	45,206 +10,209	+29%	+$457K	0.03%	303
2024 Q1	$1.9M	Sell	34,997 -280,277	-89%	-$14.3M	0.04%	275
2023 Q4	$16.2M	Buy	315,274 +221,628	+237%	+$11.6M	0.34%	75
2023 Q3	$5.43M	Sell	93,646 -42,541	-31%	-$2.61M	0.13%	139
2023 Q2	$8.71M	Sell	136,187 -16,501	-11%	-$1.11M	0.21%	112
2023 Q1	$10.6M	Sell	152,688 -95,532	-38%	-$6.74M	0.28%	90
2022 Q4	$17.9M	Buy	248,220 +25,090	+11%	+$1.89M	0.48%	60
2022 Q3	$15.9M	Sell	223,130 -2,486	-1%	-$180K	0.81%	32
2022 Q2	$17.4M	Buy	225,616 +136,293	+153%	+$10.4M	0.74%	45
2022 Q1	$6.52M	Sell	89,323 -178,809	-67%	-$12M	0.25%	87
2021 Q4	$16.7M	Sell	268,132 -88,339	-25%	-$5.18M	0.62%	54
2021 Q3	$21.1M	Buy	356,471 +241,836	+211%	+$15.9M	0.8%	36
2021 Q2	$7.66M	Buy	114,635 +16,662	+17%	+$1.09M	0.29%	88
2021 Q1	$6.18M	Sell	97,973 -143,364	-59%	-$8.92M	0.25%	100
2020 Q4	$15M	Buy	241,337 +61,620	+34%	+$3.79M	0.65%	43
2020 Q3	$10.8M	Buy	179,717 +25,961	+17%	+$1.56M	0.49%	47
2020 Q2	$9.04M	Buy	153,756 +5,169	+3%	+$309K	0.46%	45
2020 Q1	$8.28M	Buy	148,587 +35,121	+31%	+$2.15M	0.49%	46
2019 Q4	$7.28M	Buy	113,466 +43,483	+62%	+$2.49M	0.34%	52
2019 Q3	$3.55M	Buy	69,983 +60,367	+628%	+$2.84M	0.17%	104
2019 Q2	$436K	Buy	+9,616	New	+$448K	0.02%	158

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's BMY Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Bristol-Myers Squibb (BMY) stake by 82% in Q2 2026, buying an estimated $26.8M and bringing the position to 1,033,357 shares worth $59.5M. The position accounts for 0.47% of the portfolio, ranked #40.

BI Asset Management Fondsmaeglerselskab first reported a position in BMY in Q2 2019 and has held it in 29 quarters since. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

BI Asset Management Fondsmaeglerselskab held 1,033,357 shares of Bristol-Myers Squibb worth $59.5M as of Q2 2026.
BI Asset Management Fondsmaeglerselskab bought 465,977 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.8M.
Bristol-Myers Squibb made up 0.47% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #40 holding.
BI Asset Management Fondsmaeglerselskab first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 29 quarters since.
2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.